Business development: Latest News, Top Stories & Analysis

EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a dedicated contract development and manufacturing organization (CDMO) solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, …

Expansions / New Markets

Recro Works to Expand and Diversify Customer Base

April 6, 2021April 6, 2021 - by MyChesCo

MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH) announced significant recent progress in strengthening the company’s business development team to support its strategic objective of expanding and diversifying its customer …